Medpace Holdings (MEDP) Total Current Liabilities (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Total Current Liabilities came in at $1.4 billion in Q2 2026, up 17.62% YoY from $1.2 billion in Q2 2025, and up 6.72% on a QoQ basis from $1.3 billion in Q1 2026.
Medpace Holdings (MEDP) Total Current Liabilities (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Total Current Liabilities data on file, last reported at $1.4 billion in Q2 2026.
- Quarterly Total Current Liabilities rose 17.62% year-over-year to $1.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.4 billion (up 17.62% YoY) and the FY2025 annual result came in at $1.3 billion, up 21.66% from the prior year.
- Total Current Liabilities improved to $1.4 billion in Q2 2026, from $1.3 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.4 billion in Q2 2026 to a low of $579.4 million in Q1 2022.
- A 5-year average of $1.0 billion and a median of $974.9 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 85.98% — and 2023, when it dropped 3.02%.
- Tracing MEDP's Total Current Liabilities over 5 years: stood at $803.5 million in 2022, then increased by 15.14% to $925.1 million in 2023, then gained by 19.39% to $1.1 billion in 2024, then gained by 21.66% to $1.3 billion in 2025, then grew by 6.82% to $1.4 billion in 2026.
- The last three Total Current Liabilities figures came in at $1.4 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.29 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.27 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.82 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 558.26 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.58 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 1.20 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 1.79 Bn |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | 1.44 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Bn |
| Mar 31, 2026 | 1.35 Bn |
| Dec 31, 2025 | 1.34 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 1.04 Bn |
| Jun 30, 2024 | 993.09 Mn |
| Mar 31, 2024 | 956.65 Mn |
| Dec 31, 2023 | 925.13 Mn |
| Sep 30, 2023 | 848.52 Mn |
| Jun 30, 2023 | 852.44 Mn |
| Mar 31, 2023 | 881.89 Mn |
| Dec 31, 2022 | 803.47 Mn |
| Sep 30, 2022 | 820.87 Mn |
| Jun 30, 2022 | 878.96 Mn |
| Mar 31, 2022 | 579.43 Mn |
| Dec 31, 2021 | 557.22 Mn |
| Sep 30, 2021 | 517.18 Mn |